The 2021 Crohn’s & Colitis Congress® Goes Virtual
We are thrilled to announce that the Crohn’s & Colitis Congress®, a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association, will be a virtual experience taking place January 21-24, 2021.
As always, we will bring together our community of health care practitioners and researchers to continue our mission of transforming inflammatory bowel disease (IBD) care — in a new and exciting forum. Please continue to check back for updates. We look forward to seeing you virtually.
Dates to Remember
Early Bird Registration Deadline: Wednesday, September 23
Discounted Registration Deadline: Wednesday, December 11
Abstract Submission Opens: Wednesday, September 9
Abstract Submission Closes: Wednesday, October 21
Abstract Notifications: Friday, December 4
Dates to Remember
Abstract Submission
Abstract Submission Opens: Monday, September 14
Abstract Submission Closes: Wednesday, October 21
Abstract Notifications: Monday, December 7
Registration
Registration Opens: Friday, August 6
Early Bird Registration Deadline: Wednesday, November 3
Crohn's & Colitis Congress Chairs
David T. Rubin, MD, AGAF
Chair, Organizing Committee
University of Chicago
Bruce E. Sands, MD, MS, AGAF
Co-Chair, Organizing Committee
Icahn School of Medicine at Mount Sinai
Supporting Organizations
The 2021 Crohn’s & Colitis Congress is supported by educational grants from:
AbbVie Inc.
Amgen Inc.
Bristol Myers Squibb
Ferring Pharmaeuticals Inc.
Gilead Sciences, Inc.
Janssen Biotech, Inc.
Pfizer, Inc.
Salix, a division of Bausch Health US, LLC.
Takeda Pharmaceuticals U.S.A., Inc.
Media Partners
The 2021 Crohn’s & Colitis Congress is partnered with:
